Author

Julie A. K. McDonald

Imperial College LondonORCID 0000-0003-0739-6047Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alex J. H. FedoreciD· 1 shared Alexander YipiD· 1 shared Benjamin Harvey MullishiD· 1 shared Chania ClareiD· 1 shared Chris P. BarnesiD· 1 shared Jack W. RutteriD· 1 shared Jesús Miguéns BlancoiD· 1 shared Julian Roberto MarchesiiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSynthetic Biology

Alex J. H. FedorecORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologyNature CommunicationsPeer-reviewedJul 10, 2025

Vancomycin-resistant enterococci colonise the antibiotic-treated intestine by occupying overlapping but distinct nutrient- and metabolite-defined intestinal niches

Olivia G. King, Alexander Yip, Victoria Horrocks…·Julie A. K. McDonald

This study shows that VRE colonize the antibiotic-treated intestine by occupying distinct nutrient-defined niches, using specific nutrients and resisting inhibitory metabolites.

20 citationstop 3%

humanmetabolomics

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintOct 9, 2023

An antimicrobial peptide expression platform for targeting pathogenic bacterial species

Jack W. Rutter, Linda Dekker, Chania Clare…·Chris P. Barnes

The paper develops a modular platform for expressing and secreting bacteriocins from non-pathogenic E. coli to target pathogenic bacteria, demonstrating antimicrobial activity and modeling strain interactions.

1 citation

E. colihuman

𝕏 PostBluesky